Last $3.19 USD
Change Today -0.06 / -1.85%
Volume 167.8K
CUR On Other Exchanges
As of 1:18 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

neuralstem inc (CUR) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/4/14 - $4.81
52 Week Low
07/29/13 - $1.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEURALSTEM INC (CUR)

neuralstem inc (CUR) Related Bloomberg News

View More Bloomberg News

neuralstem inc (CUR) Related Businessweek News

No Related Businessweek News Found

neuralstem inc (CUR) Details

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. The company’s stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical program products include NSI–566, which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, and Phase I clinical trials for chronic spinal cord injury. The company’s clinical development products also comprise NSI–566 that is in Phase I/II clinical trials for motor deficits due to ischemic stroke in China; and NSI–189 that is in Phase Ib for the treatment of major depressive disorders. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.

15 Employees
Last Reported Date: 05/12/14
Founded in 1996

neuralstem inc (CUR) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $651.2K
Co-Founder, Chairman and Chief Scientific Off...
Total Annual Compensation: $675.4K
Senior Vice President of Research
Total Annual Compensation: $281.3K
Compensation as of Fiscal Year 2013.

neuralstem inc (CUR) Key Developments

Neuralstem, Inc.(AMEX:CUR) added to Russell 2000 Index

Neuralstem, Inc. will be added to the Russell 2000 Index.

Neuralstem, Inc.(AMEX:CUR) added to Russell 3000 Index

Neuralstem, Inc. will be added to the Russell 3000 Index.

Neuralstem, Inc. Approves Amendment to the Company’s Amended and Restated Certificate of Incorporation

Neuralstem, Inc. approved the amendment to the Company’s amended and restated certificate of incorporation to increase the Company’s authorized capital by 150,000,000 shares of common stock, at the company's AGM held on June 27, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CUR:US $3.20 USD -0.05

CUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aastrom Biosciences Inc $3.26 USD -0.0801
Advanced Cell Technology Inc $0.07 USD -0.0052
BioTime Inc $2.71 USD +0.10
International Stem Cell Corp $0.12 USD +0.0101
ReNeuron Group PLC 3.45 GBp +0.025
View Industry Companies

Industry Analysis


Industry Average

Valuation CUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 24,395.1x
Price/Book 10.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 21,222.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEURALSTEM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at